Xtant Medical Holdings (XTNT) Amortizatization of Intangibles (2011 - 2015)
Xtant Medical Holdings' (XTNT) quarterly Amortizatization of Intangibles came in at -$141492.0 in Q3 2015, down 130.19% year-on-year from $468732.0 in Q3 2014, and down 133.34% on a QoQ basis from $424386.0 in Q2 2015.
Xtant Medical Holdings (XTNT) Amortizatization of Intangibles (2011 - 2015) Analysis & Trends
Xtant Medical Holdings (XTNT) has 5 years of Amortizatization of Intangibles data on file, last reported at -$141492.0 in Q3 2015.
- On a quarterly basis, Amortizatization of Intangibles fell 130.19% year-over-year to -$141492.0 in Q3 2015; TTM through Mar 2016 was $282894.0, a 83.34% decrease from a year earlier, with the FY2015 full-year figure at $707281.0, down 56.67% from the prior year.
- Amortizatization of Intangibles for Q3 2015 stood at -$141492.0, down from $424386.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for XTNT reached as high as $1.0 million in Q3 2011 and fell as low as -$1.0 million in Q4 2011.
- Historically, Amortizatization of Intangibles has averaged $242773.5 across 5 years, with a median of $333972.0 in 2013.
- Across the five-year window, Amortizatization of Intangibles surged 1143.7% in 2013 and plunged 130.19% in 2015, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$1.0 million in 2011, then surged by 127.21% to $273539.0 in 2012, then advanced by 22.09% to $333972.0 in 2013, then climbed by 27.07% to $424386.0 in 2014, then sank by 133.34% to -$141492.0 in 2015.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were -$141492.0 in Q3 2015, $424386.0 in Q2 2015, and $424387.0 in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Xtant Medical Holdings | 60.50 Mn | 43.17 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | -141,492.00 |
| Sep 30, 2015 | -141,492.00 |
| Jun 30, 2015 | 424,386.00 |
| Jun 30, 2015 | 424,386.00 |
| Mar 31, 2015 | 424,387.00 |
| Mar 31, 2015 | 424,387.00 |
| Dec 31, 2014 | 424,386.00 |
| Dec 31, 2014 | 424,386.00 |
| Sep 30, 2014 | 468,732.00 |
| Sep 30, 2014 | 468,732.00 |
| Jun 30, 2014 | 380,040.00 |
| Jun 30, 2014 | 380,040.00 |
| Mar 31, 2014 | 359,087.00 |
| Mar 31, 2014 | 359,087.00 |
| Dec 31, 2013 | 333,972.00 |
| Dec 31, 2013 | 333,972.00 |
| Sep 30, 2013 | 333,972.00 |
| Sep 30, 2013 | 333,972.00 |
| Jun 30, 2013 | 333,972.00 |
| Jun 30, 2013 | 333,972.00 |